Atlas Trials

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Clinical trial NCT02470299 · COMPLETED

Trial details

NCT number
NCT02470299
Sponsor
New Mexico Cancer Research Alliance
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Start date
2015-10-29
Primary completion
2018-10-08
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.